{
  "reasoning": "The original query focuses on the affordability and access to generic drugs in Africa, highlighting economic conditions and specific examples like the cost disparity between patented and generic versions of Glivec. The intent appears informational, aiming to explore how affordable medications can improve health outcomes amid wealth inequality. Existing results emphasize various impacts of generics but lack depth regarding local production capacity, socioeconomic factors beyond drug pricing, and solutions for these challenges. To enhance this search query, a conceptual graph will be constructed with core concepts from the query at its center, branching out into relevant expansions that address identified weaknesses. The goal is to uncover high-value terms related to economic policies, healthcare infrastructure, and regional production capabilities. Through thoughtful expansion of the query via paths like hierarchical terms (e.g., broader economic implications), contextual terms (settings/scenarios impacting drug access), and domain-specific terminology (e.g., health policy in Africa), new angles will be explored to provide a more comprehensive understanding.",
  "query_goals": [
    "Understand the impact of generic drugs on healthcare affordability in Africa",
    "Explore socioeconomic factors affecting drug accessibility beyond pricing",
    "Identify local production capacity for generic medications within African countries"
  ],
  "node_classes": [
    "Generic Drugs",
    "Economic Conditions",
    "Healthcare Access",
    "Regional Production",
    "Policy Solutions",
    "Wealth Distribution",
    "Market Dynamics",
    "Drug Safety and Efficacy",
    "Health Outcomes"
  ],
  "query_nodes": [
    "Affordable drugs",
    "Generic drugs",
    "GDP growth in Africa",
    "Economic condition in Africa",
    "Glivec vs generic drug pricing"
  ],
  "nearest_neighbors": [
    "Economic development policies in Africa",
    "Healthcare infrastructure improvements",
    "Local pharmaceutical manufacturing capabilities",
    "Distribution of wealth and economic inequality",
    "Generic drug production regulations",
    "Impact of affordable healthcare on mortality rates",
    "Role of international trade in generic drugs",
    "Public health policy interventions",
    "Collaborations for local drug production",
    "Market dynamics affecting drug pricing"
  ],
  "augmented_query": "Easily affordable drugs mean greater access; Generic drugs are much cheaper to produce, ideal for Africa's struggling population. While GDP growth exists in Africa, wealth distribution is unequal\u201453% feel economically poor, limiting high-cost drug purchases. Generic medications reduce prices, enhancing affordability. Glivec costs \u00a348.62/400mg, while its Indian generic equivalent costs \u00a34.82. Increased access boosts treatment levels, reducing death from preventable diseases. Examine economic development policies in Africa, healthcare infrastructure improvements, local pharmaceutical manufacturing capabilities, wealth distribution, and public health policy interventions.",
  "ndcg": {
    "NDCG@10": 0.63093,
    "NDCG@100": 0.63093,
    "NDCG@1000": 0.63093,
    "NDCG@10000": 0.63093
  },
  "map": {
    "MAP@10": 0.5,
    "MAP@100": 0.5,
    "MAP@1000": 0.5,
    "MAP@10000": 0.5
  },
  "recall": {
    "Recall@10": 1.0,
    "Recall@100": 1.0,
    "Recall@1000": 1.0,
    "Recall@10000": 1.0
  },
  "precision": {
    "P@10": 0.1,
    "P@100": 0.01,
    "P@1000": 0.001,
    "P@10000": 0.0001
  },
  "delta": 0.13093,
  "instruction": "graph",
  "query": "Easily affordable drugs will mean greater access  Generic drugs are much cheaper to produce, which is ideal for Africa\u2019s struggling population. While there has been significant gross domestic product (GDP) growth in Africa, the actual distribution of wealth is relatively unequal. According to Afrobarometer, 53% of Africans still feel that their economic condition is poor [1] . This restricts their ability to purchase high cost drugs. Generic medication would reduce the price of these drugs, making them affordable to the average citizen. The patented drug Glivec, used for cancer treatment, costs \u00a348.62 for 400 mg in South Africa while its generic equivalent (produced in India) costs \u00a34.82 [2] . Increased access will result in higher levels of treatment, which in turn will reduce death rates from preventable diseases in Africa.  [1] Hofmeyr, Jan, \u2018Africa Rising? Popular Dissatisfaction with Economic Management Despite a Decade of Growth\u2019  [2] Op Cit",
  "query_id": "test-health-dhiacihwph-pro01a",
  "dataset": "arguana",
  "generator_model": "ollama_chat/phi4:14b-q8_0",
  "temperature": 1.0,
  "thought_process": "Looking at the original query about easily affordable drugs meaning greater access, particularly in the context of Africa's struggling population and the significant cost difference between patented drugs like Glivec and their generic equivalents, this makes me think of the broader implications of generic drug availability on healthcare access and outcomes. The user might actually be trying to understand not just the economic factors but also the policy, infrastructure, and production capacity aspects that influence drug accessibility. However, I'm not sure yet how to systematically expand this query to capture all relevant dimensions without diluting its focus.\n\nI'm seeing several possibilities here, but let me approach this using the technique of Query Expansion via Conceptual Graph Traversal, which involves analyzing the query, constructing a conceptual graph, selecting expansion paths, extracting and filtering terms, and finally, formulating an augmented query. This technique should help because it provides a structured way to identify and organize relevant concepts and terms around the core query, ensuring that the expansion is both comprehensive and precise.\n\nStarting with the query analysis, the core concepts are generic drugs, affordability, access to healthcare, economic conditions in Africa, and the impact on health outcomes. The search intent is clearly informational, aiming to explore how affordable medications can improve health outcomes amidst wealth inequality. An implicit assumption here is that increasing access to affordable drugs will lead to better health outcomes, but there might be constraints related to drug safety, efficacy, and the regulatory environment that need consideration.\n\nMoving to graph construction, the core nodes include generic drugs, economic conditions, healthcare access, and health outcomes. First-order connections would involve the cost-effectiveness of generic drugs, the relationship between economic conditions and drug accessibility, and how healthcare access affects health outcomes. Second-order connections might include policy interventions, pharmaceutical manufacturing capabilities, and the role of international trade in generic drugs. Domain contexts would involve healthcare policy, economic development, and pharmaceutical regulation in Africa.\n\nFor expansion path selection, I identify promising directions such as synonymous terms (e.g., \"affordable medications\" instead of \"easily affordable drugs\"), hierarchical terms (e.g., \"pharmaceuticals\" as a broader concept than \"generic drugs\"), compositional terms (e.g., \"drug production costs\" as a component of \"affordability\"), contextual terms (e.g., \"rural areas\" as a specific setting where drug access might be limited), and domain-specific terminology (e.g., \"essential medicines\" as a field-specific concept).\n\nFollowing the technique's steps, I apply the expansion paths systematically. For synonymous terms, I consider \"affordable medications,\" \"cheap drugs,\" and \"low-cost treatments.\" For hierarchical terms, \"pharmaceuticals,\" \"medicines,\" and \"healthcare products\" are relevant. Compositional terms like \"drug production,\" \"distribution networks,\" and \"regulatory frameworks\" offer insight into the mechanics of drug accessibility. Contextual terms such as \"healthcare infrastructure,\" \"rural healthcare,\" and \"community health services\" provide scenarios where drug access is critical. Domain-specific terminology includes \"health policy,\" \"pharmaceutical regulation,\" and \"medical ethics.\"\n\nAs I apply these expansion paths, I notice that some terms are more directly relevant than others. For instance, \"pharmaceutical regulation\" and \"health policy\" are highly relevant because they directly influence the availability and affordability of generic drugs. On the other hand, \"medical ethics\" while important, is somewhat tangential to the main query about access and affordability.\n\nInterspersing the systematic application of the technique with natural cognitive elements, I find myself occasionally reconsidering the inclusion of certain terms. For example, I initially thought to include \"patient advocacy groups\" as a contextual term, but upon further reflection, I realize that while they are important for drug access, they might not directly relate to the economic and policy aspects of generic drug availability.\n\nThrough this process, insights emerge from both the structured technique and my intuitive connections. Applying the conceptual graph traversal technique leads me to discover terms like \"local pharmaceutical manufacturing\" and \"regional trade agreements,\" which are crucial for understanding how generic drugs can be made more accessible in Africa. My instinct also suggests considering the role of \"international health organizations\" and \"non-governmental organizations (NGOs)\" in facilitating access to affordable drugs, which complements the technique's outcomes.\n\nSynthesizing the expanded terms with clarity, I believe that terms such as \"generic drug production,\" \"healthcare infrastructure development,\" \"pharmaceutical policy in Africa,\" \"economic development strategies,\" \"regulatory frameworks for generics,\" and \"international collaborations for drug access\" would be highly effective for exploring the impact of generic drugs on healthcare affordability in Africa. These terms capture both the explicit and implicit aspects of what the user is seeking, including economic, policy, and infrastructure factors that influence drug accessibility and health outcomes.\n\nThus, the final expanded query would incorporate these insights, aiming to provide a comprehensive understanding of how generic drugs can improve healthcare",
  "though_generator": "openrouter/meta-llama/llama-3.3-70b-instruct"
}